Literature DB >> 9629313

[Comparison between invasive tests for the diagnosis of Helicobacter pylori infections].

M Morais1, E P Macedo, M R da Silva Júnior, M R Rohr, M L Ferraz, R R Castro, E Della Libera, E S Siqueira, C Q Brant, A P Ferrari Junior.   

Abstract

Helicobacter pylori is a Gram negative bacteria that colonizes gastric epithelial cells. It has been associated with several gastric disease including chronic gastritis and peptic ulcer. Helicobacter pylori infection diagnosis can be done with invasive and non-invasive methods. In invasive methods an endoscopic gastric mucosa biopsy specimen is used. In our study we compare the sensitivity, specificity, costs and applicability of four invasive diagnostic tests: culture, urease ultra-rapid test, histology (Giemsa and Hematoxilineosin stain) and fuchsin stained mucosal slides. Urease test was the easiest, fastest diagnostic test, with sensitivity of 86% and specificity of 100%, being also the cheapest test. We concluded that it should be the test of choice for Helicobacter pylori infection diagnosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9629313

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  3 in total

1.  CONVENTIONAL VIDEOENDOSCOPY CAN IDENTIFY HELICOBACTER PYLORI GASTRITIS?

Authors:  Alexandre Gomes; Thelma Larocca Skare; Manoel Alberto Prestes; Maiza da Silva Costa; Roberta Dombroski Petisco; Gabriela Piovezani Ramos
Journal:  Arq Bras Cir Dig       Date:  2016 Apr-Jun

2.  Antral exfoliative cytology for the detection of Helicobacter pylori in the stomach.

Authors:  Claudio A R Gomes; Wilson R Catapani; Ana M A A Mader; Angelo Locatelli; Claudilene B- P Silva; Jaques Waisberg
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

3.  Evaluation of the efficacy of triple therapy regimen for Helicobacter pylori eradication in gastrectomized patients with gastric adenocarcinoma.

Authors:  Jose Luiz Bertoli Neto; Laercio Gomes Lourenço; Cícero Fernando Bertoli; Fábio Samsonowski Ulbrich; Antoninho Ricardo Sabbi; Alexandre Galvão Bueno
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.